Report Detail
Global (United States, European Union and China) Human Growth Hormone Drugs Market Research Report 2019-2025
- RnM3663740 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet.
Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient’s working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers.
In 2019, the market size of Human Growth Hormone Drugs is 37000 million US$ and it will reach 66500 million US$ in 2025, growing at a CAGR of 7.6% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Growth Hormone Drugs.
This report studies the global market size of Human Growth Hormone Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Growth Hormone Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Market Segment by Product Type
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope
Somatropin Biopartners
Market Segment by Application
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Human Growth Hormone Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Growth Hormone Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Human Growth Hormone Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Norditropin
- 1.3.3 Genotropin
- 1.3.4 Humatrope
- 1.3.5 Saizen
- 1.3.6 Omnitrope
- 1.3.7 Somatropin Biopartners
- 1.4 Market Segment by Application
- 1.4.1 Global Human Growth Hormone Drugs Market Share by Application (2019-2025)
- 1.4.2 Prader-Willi Syndrome
- 1.4.3 Turner Syndrome
- 1.4.4 Short Stature Homeobox Gene
- 1.4.5 Small for Gestational Age
- 1.4.6 Chronic Renal Insufficiency
- 1.4.7 Short Bowel Syndrome
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Human Growth Hormone Drugs Market Size
- 2.1.1 Global Human Growth Hormone Drugs Revenue 2014-2025
- 2.1.2 Global Human Growth Hormone Drugs Sales 2014-2025
- 2.2 Human Growth Hormone Drugs Growth Rate by Regions
- 2.2.1 Global Human Growth Hormone Drugs Sales by Regions 2014-2019
- 2.2.2 Global Human Growth Hormone Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Human Growth Hormone Drugs Sales by Manufacturers
- 3.1.1 Human Growth Hormone Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Human Growth Hormone Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Human Growth Hormone Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Growth Hormone Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Human Growth Hormone Drugs Price by Manufacturers
- 3.4 Key Manufacturers Human Growth Hormone Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Human Growth Hormone Drugs Market
- 3.6 Key Manufacturers Human Growth Hormone Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Norditropin Sales and Revenue (2014-2019)
- 4.1.2 Genotropin Sales and Revenue (2014-2019)
- 4.1.3 Humatrope Sales and Revenue (2014-2019)
- 4.1.4 Saizen Sales and Revenue (2014-2019)
- 4.1.5 Omnitrope Sales and Revenue (2014-2019)
- 4.1.6 Somatropin Biopartners Sales and Revenue (2014-2019)
- 4.2 Global Human Growth Hormone Drugs Sales Market Share by Type
- 4.3 Global Human Growth Hormone Drugs Revenue Market Share by Type
- 4.4 Human Growth Hormone Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Human Growth Hormone Drugs Sales by Application
6 United States
- 6.1 United States Human Growth Hormone Drugs Breakdown Data by Company
- 6.2 United States Human Growth Hormone Drugs Breakdown Data by Type
- 6.3 United States Human Growth Hormone Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Human Growth Hormone Drugs Breakdown Data by Company
- 7.2 European Union Human Growth Hormone Drugs Breakdown Data by Type
- 7.3 European Union Human Growth Hormone Drugs Breakdown Data by Application
8 China
- 8.1 China Human Growth Hormone Drugs Breakdown Data by Company
- 8.2 China Human Growth Hormone Drugs Breakdown Data by Type
- 8.3 China Human Growth Hormone Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Human Growth Hormone Drugs Breakdown Data by Company
- 9.2 Rest of World Human Growth Hormone Drugs Breakdown Data by Type
- 9.3 Rest of World Human Growth Hormone Drugs Breakdown Data by Application
- 9.4 Rest of World Human Growth Hormone Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Human Growth Hormone Drugs Sales by Countries
- 9.4.2 Rest of World Human Growth Hormone Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Eli Lilly and Company (US)
- 10.1.1 Eli Lilly and Company (US) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.1.4 Human Growth Hormone Drugs Product Introduction
- 10.1.5 Eli Lilly and Company (US) Recent Development
- 10.2 Ferring Holding SA (Switzerland)
- 10.2.1 Ferring Holding SA (Switzerland) Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.2.4 Human Growth Hormone Drugs Product Introduction
- 10.2.5 Ferring Holding SA (Switzerland) Recent Development
- 10.3 Genentech, Inc. (US)
- 10.3.1 Genentech, Inc. (US) Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.3.4 Human Growth Hormone Drugs Product Introduction
- 10.3.5 Genentech, Inc. (US) Recent Development
- 10.4 GeneScience Pharmaceuticals Co., Ltd. (China)
- 10.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.4.4 Human Growth Hormone Drugs Product Introduction
- 10.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
- 10.5 Merck KgaA (Germany)
- 10.5.1 Merck KgaA (Germany) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.5.4 Human Growth Hormone Drugs Product Introduction
- 10.5.5 Merck KgaA (Germany) Recent Development
- 10.6 Novo Nordisk A/S (Denmark)
- 10.6.1 Novo Nordisk A/S (Denmark) Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.6.4 Human Growth Hormone Drugs Product Introduction
- 10.6.5 Novo Nordisk A/S (Denmark) Recent Development
- 10.7 Pfizer, Inc. (US)
- 10.7.1 Pfizer, Inc. (US) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.7.4 Human Growth Hormone Drugs Product Introduction
- 10.7.5 Pfizer, Inc. (US) Recent Development
- 10.8 Sandoz International GmbH (Germany)
- 10.8.1 Sandoz International GmbH (Germany) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Human Growth Hormone Drugs
- 10.8.4 Human Growth Hormone Drugs Product Introduction
- 10.8.5 Sandoz International GmbH (Germany) Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Human Growth Hormone Drugs Sales Channels
- 11.2.2 Human Growth Hormone Drugs Distributors
- 11.3 Human Growth Hormone Drugs Customers
12 Market Forecast
- 12.1 Global Human Growth Hormone Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Human Growth Hormone Drugs Sales Forecast by Type
- 12.3 Global Human Growth Hormone Drugs Sales Forecast by Application
- 12.4 Human Growth Hormone Drugs Forecast by Regions
- 12.4.1 Global Human Growth Hormone Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Human Growth Hormone Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Human Growth Hormone Drugs. Industry analysis & Market Report on Human Growth Hormone Drugs is a syndicated market report, published as Global (United States, European Union and China) Human Growth Hormone Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Human Growth Hormone Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
